GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Ajooni Biotech Ltd (NSE:AJOONI) » Definitions » Debt-to-Revenue

Ajooni Biotech (NSE:AJOONI) Debt-to-Revenue : 0.03 (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ajooni Biotech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Ajooni Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹34.3 Mil. Ajooni Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2023 was ₹17.5 Mil. Ajooni Biotech's annualized Revenue for the quarter that ended in Mar. 2023 was ₹1,650.2 Mil. Ajooni Biotech's annualized Debt-to-Revenue for the quarter that ended in Mar. 2023 was 0.03.


Ajooni Biotech Debt-to-Revenue Historical Data

The historical data trend for Ajooni Biotech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajooni Biotech Debt-to-Revenue Chart

Ajooni Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.13 0.13 0.07 0.07

Ajooni Biotech Quarterly Data
Mar15 Mar16 Mar17 Aug17 Mar18 Sep18 Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.13 0.16 0.18 0.03

Competitive Comparison of Ajooni Biotech's Debt-to-Revenue

For the Packaged Foods subindustry, Ajooni Biotech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajooni Biotech's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Ajooni Biotech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ajooni Biotech's Debt-to-Revenue falls into.



Ajooni Biotech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Ajooni Biotech's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(34.303 + 17.466) / 744.877
=0.07

Ajooni Biotech's annualized Debt-to-Revenue for the quarter that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(34.303 + 17.466) / 1650.236
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2023) Revenue data.


Ajooni Biotech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ajooni Biotech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajooni Biotech Business Description

Traded in Other Exchanges
N/A
Address
D-118, Industrial Area, Phase VII, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in the production of animal feed. The company's products of cattle feed include Nurture Calf Starter, Winner 10ltr, Hiffer/Grower, Energy Plus, Eco- 5ltr, Milk Booster, & Buff Power, and its feed supplements include Autovita, Livtus, Caltus, Rumitus, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.

Ajooni Biotech Headlines

No Headlines